The Research Service of the Verkhovna Rada of Ukraine has prepared an analytical note on comparative legislation governing the public procurement of medicinal products and medical devices in the European Union and selected Member States. The document examines EU legislation and the experience of selected Member States to identify possible ways to improve Ukraine’s legal framework for public procurement in the healthcare sector.
The analytical note reviews the key provisions of Directive 2014/24/EU on public procurement, particularly those concerning procurement procedures, the use of framework agreements, the operation of central purchasing bodies and joint procurement arrangements. Particular attention is paid to the criteria for evaluating tenders, including quality, clinical effectiveness, innovation, the life-cycle costs of medical equipment, its compatibility with existing systems, maintenance and support services, and sustainability considerations.
The note examines the legislative frameworks and practices of France, Germany, Spain, Sweden, Poland and Czechia in organising public procurement of medicinal products and medical devices. In particular, it explores procurement arrangements at national, regional and individual healthcare institution levels, mechanisms for aggregating purchasing needs, and approaches to procuring high-cost medical equipment.
The document also reviews measures taken by the EU and individual Member States to prevent shortages of critical medicinal products, maintain adequate stocks and ensure continuity of supply. It outlines current trends in the development of EU public procurement legislation, aimed at simplifying procedures, reducing administrative burdens, strengthening competition and encouraging greater participation by small and medium-sized enterprises.
The full text of the analytical note is available at the following link:
